[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053682":3},{"organization":4,"outcomesModule":7,"designInfo":30,"detailedDescription":36,"studyPopulation":29,"armGroups":37,"interventions":44,"overallOfficials":49,"centralContacts":53,"locations":59,"responsibleParty":82,"collaborators":84,"id":88,"slug":29,"hasResults":89,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":29,"eligibilityCriteria":93,"healthyVolunteers":89,"sex":94,"minAge":95,"maxAge":96,"enrollmentInfo":97,"targetDuration":29,"studyType":100,"phases":101,"briefSummary":102,"conditions":103,"keywords":29,"overallStatus":105,"whyStopped":29,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":110,"completionDateStruct":112,"leadSponsor":114,"locationsCount":115},{"fullName":5,"class":6},"Yale University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":29,"otherOutcomes":29},[9,13,17,20,23,26],{"measure":10,"description":11,"timeFrame":12},"Recruitment rate","Number and proportion of eligible individuals who enroll","Day 1",{"measure":14,"description":15,"timeFrame":16},"Retention rate","Number of enrolled participants who complete the 12-week study","12 weeks",{"measure":18,"description":19,"timeFrame":16},"Frequency of app usage- Adherence","Mean number of times app was utilized",{"measure":21,"description":22,"timeFrame":16},"Duration of workout- Adherence","Mean duration of workout in minutes",{"measure":24,"description":25,"timeFrame":16},"Mean score Borg Scale of Rating of Perceived Exertion","Measures exertion on a total scale of 0 (no exertion or resting) to 10 (pushing yourself to the max).",{"measure":27,"description":28,"timeFrame":16},"Data completeness","Proportion of expected study data successfully collected at each time point",null,{"allocation":31,"interventionModel":32,"interventionModelDescription":29,"primaryPurpose":33,"observationalModel":29,"timePerspective":29,"maskingInfo":34},"NA","SINGLE_GROUP","TREATMENT",{"masking":35,"maskingDescription":29,"whoMasked":29},"NONE","Study activities will include:\n\nCompletion of health questionnaires Participation in a 12-week exercise program using a mobile application Having your exercise activity tracked through the mobile application Reporting any symptoms or infections that develop Providing blood samples for immune-related testing at your patient visits. Completion of assessments at the beginning and end of study",[38],{"label":39,"type":40,"description":41,"interventionNames":42},"App-based exercise intervention","EXPERIMENTAL","12-week, app-based exercise intervention in adults with primary antibody deficiencies with completion of survey procedures and collection of clinical and laboratory data",[43],"Behavioral: App-based exercise intervention",[45],{"type":46,"name":39,"description":47,"armGroupLabels":48,"otherNames":29},"BEHAVIORAL","12 week structured moderate-intensity exercise intervention delivered via a mobile application",[39],[50],{"name":51,"affiliation":5,"role":52},"Ryan Steele, DO, MSc","PRINCIPAL_INVESTIGATOR",[54],{"name":51,"role":55,"phone":56,"phoneExt":57,"email":58},"CONTACT","203-785-7092","57092","r.steele@yale.edu",[60,73],{"facility":61,"status":29,"city":62,"state":63,"zip":64,"country":65,"countryCode":66,"cosmosGeoPoint":67,"geoPoint":72,"contacts":29},"Bridgeport Hospital","Milford","Connecticut","06460","United States","US",{"type":68,"coordinates":69},"Point",[70,71],-73.0565,41.22232,{"lat":71,"lon":70},{"facility":74,"status":29,"city":75,"state":63,"zip":76,"country":65,"countryCode":66,"cosmosGeoPoint":77,"geoPoint":81,"contacts":29},"Yale New Haven Health","North Haven","06473",{"type":68,"coordinates":78},[79,80],-72.85954,41.39093,{"lat":80,"lon":79},{"type":83,"investigatorFullName":29,"investigatorTitle":29,"investigatorAffiliation":29,"oldNameTitle":29,"oldOrganization":29},"SPONSOR",[85],{"name":86,"class":87},"The Pump","UNKNOWN","100053682",false,"NCT07698197","Exercise Intervention and Immunodeficiency","Exercise Intervention in Primary Antibody Deficiency Disorders: A 12-week Feasibility Study","Inclusion Criteria:\n\n* Diagnosed with one of the following primary antibody deficiencies: IgG subclass deficiency, selective IgA deficiency, selective IgM deficiency, or specific antibody deficiency\n* Receiving care in the Section of Rheumatology, Allergy \\& Immunology\n* Able and willing to participate in a moderate-intensity exercise program. Patients will be screened using the American College of Sports Medicine (ACSM) Pre- participation Screening Guidelines. This algorithm assesses patients for cardiovascular, renal, and metabolic disease. Those patients determined to not require further medical clearance to participate in exercise will be included.\n\nExclusion Criteria:\n\n* Receipt of immunoglobulin (Ig) replacement therapy\n* Use of immunosuppressive or immunomodulatory medications (e.g., chronic systemic corticosteroids, B-cell-depleting therapies)\n* Medical contraindications to moderate-intensity exercise as determined by clinical assessment using the previously discussed ACSM Pre-participation Screening Guidelines.\n* Other risk factors\u002Fmedical conditions that would limit safe participation in exercise as determined by clinical assessment, including active rheumatologic conditions including active rheumatoid arthritis.","ALL","18 Years","65 Years",{"count":98,"type":99},20,"ESTIMATED","INTERVENTIONAL",[31],"The purpose of this study is to assess if a 12-week exercise program is safe, practical, and acceptable for adults with primary antibody deficiencies. It also looks at whether the program can improve the quality of life and help the immune system work better.",[104],"Primary Antibody Deficiency Disorders","NOT_YET_RECRUITING","2026-07-06",{"date":108,"type":109},"2026-07-13","ACTUAL",{"date":111,"type":99},"2026-07",{"date":113,"type":99},"2027-07",{"name":5,"class":6},2]